The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases

被引:11
|
作者
Palomares, O. [1 ]
Crameri, R. [2 ]
Rhyner, C. [2 ]
机构
[1] Univ Complutense Madrid, Dept Biochem & Mol Biol, Sch Chem, E-28040 Madrid, Spain
[2] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland
基金
瑞士国家科学基金会;
关键词
allergy; biotechnology; immunotherapy; recombinant allergens; HOUSE-DUST MITE; BET V 1; THYMIC STROMAL LYMPHOPOIETIN; COMPONENT-RESOLVED DIAGNOSIS; INTESTINAL EPITHELIAL-CELLS; MYELOID DENDRITIC CELLS; SITE-DIRECTED MUTAGENESIS; EUROPEAN HEALTH-CARE; EAACI POSITION PAPER; VIRUS-LIKE PARTICLES;
D O I
10.1111/all.12533
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Biotechnology' has been intuitively used by humans since thousands of years for the production of foods, beverages, and drugs based on the experience without any scientific background. However, the golden era of this discipline emerged only during the second half of the last century. Incredible progresses have been achieved on all fields starting from the industrialization of the production of foods to the discovery of antibiotics, the decipherment of the genetic code, and rational approaches to understand and define the status we now call healthy'. The extremely complex interactions between genetic background, life style, and environmental factors influencing our continuously increasing life span have become more and more evident and steadily generate new questions which are only partly answered. Here, we try to summarize the contribution of biotechnology to our understanding, control, and cure of IgE-mediated allergic diseases. We are aware that a review of such a vast topic can never cover all aspects of the progress achieved in the different fields.
引用
收藏
页码:1588 / 1601
页数:14
相关论文
共 50 条